Harbor Capital Advisors Inc. Sells 1,983 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

Harbor Capital Advisors Inc. reduced its stake in Privia Health Group, Inc. (NASDAQ:PRVA) by 6.6% during the third quarter, HoldingsChannel reports. The firm owned 27,951 shares of the company’s stock after selling 1,983 shares during the period. Harbor Capital Advisors Inc.’s holdings in Privia Health Group were worth $509,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Canada Pension Plan Investment Board purchased a new stake in shares of Privia Health Group during the 2nd quarter valued at $26,000. GAMMA Investing LLC increased its stake in Privia Health Group by 98.7% in the third quarter. GAMMA Investing LLC now owns 1,701 shares of the company’s stock valued at $31,000 after acquiring an additional 845 shares during the last quarter. Nisa Investment Advisors LLC lifted its stake in Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock worth $31,000 after purchasing an additional 930 shares during the last quarter. Signaturefd LLC lifted its stake in Privia Health Group by 46.3% during the second quarter. Signaturefd LLC now owns 1,978 shares of the company’s stock worth $34,000 after purchasing an additional 626 shares during the last quarter. Finally, Values First Advisors Inc. purchased a new position in shares of Privia Health Group in the 3rd quarter worth about $83,000. 94.48% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of analysts recently weighed in on the company. KeyCorp assumed coverage on Privia Health Group in a research report on Friday, October 11th. They issued an “overweight” rating and a $23.00 target price for the company. Robert W. Baird boosted their price objective on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an “outperform” rating in a report on Monday, August 26th. Finally, Royal Bank of Canada reaffirmed an “outperform” rating and set a $28.00 target price on shares of Privia Health Group in a report on Wednesday, August 14th. Two investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Buy” and an average target price of $24.73.

Privia Health Group Price Performance

PRVA opened at $21.16 on Thursday. Privia Health Group, Inc. has a one year low of $15.92 and a one year high of $24.35. The business has a 50 day simple moving average of $18.34 and a two-hundred day simple moving average of $18.29. The firm has a market capitalization of $2.53 billion, a price-to-earnings ratio of 176.35, a PEG ratio of 4.36 and a beta of 0.76.

Privia Health Group (NASDAQ:PRVA) last announced its earnings results on Thursday, August 8th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The business had revenue of $422.30 million for the quarter, compared to the consensus estimate of $411.50 million. Privia Health Group had a net margin of 0.88% and a return on equity of 2.42%. Privia Health Group’s revenue was up 2.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.06 EPS. As a group, sell-side analysts expect that Privia Health Group, Inc. will post 0.17 EPS for the current fiscal year.

Insider Buying and Selling at Privia Health Group

In other news, CEO Parth Mehrotra sold 135,142 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $18.50, for a total value of $2,500,127.00. Following the completion of the sale, the chief executive officer now directly owns 247,771 shares of the company’s stock, valued at approximately $4,583,763.50. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Insiders own 14.20% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.